Related references
Note: Only part of the references are listed.Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
Chih-Cheng Lai et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
Kimiyasu Shiraki et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Liying Dong et al.
DRUG DISCOVERIES AND THERAPEUTICS (2020)
Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
Leen Delang et al.
ANTIVIRAL RESEARCH (2018)
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
Yousuke Furuta et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2017)
Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis
Evelien Vanderlinden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Favipiravir: A New Medication for the Ebola Virus Disease Pandemic
Takashi Nagata et al.
DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS (2015)
The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
David Safronetz et al.
SCIENTIFIC REPORTS (2015)
Favipiravir (T-705), a novel viral RNA polymerase inhibitor
Yousuke Furuta et al.
ANTIVIRAL RESEARCH (2013)
T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
Tatiana Baranovich et al.
JOURNAL OF VIROLOGY (2013)
Favipiravir (T-705) inhibits in vitro norovirus replication
J. Rocha-Pereira et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture
Michelle Mendenhall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells
Donald F. Smee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections
Brian B. Gowen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Efficacy of orally administered T-705 on lethal avian influenza a (H5N1) virus infections in mice
Robert W. Sidwell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Mechanism of action of T-705 against influenza virus
Y Furuta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
In vitro and in vivo activities of anti-influenza virus compound T-705
Y Furuta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
